Keith Michael Gottesdiener's Net Worth
Keith Michael Gottesdiener's net worth is estimated to be at least $2,537,103.84 as of 05/18/2024. CoreStreet's estimation of Keith Michael Gottesdiener's net worth is based on their sale of stock and current holding of stock.
Keith Michael Gottesdiener is CEO at Rhythm Pharmaceuticals Inc. They have executed at least 10 trades of stock as per SEC Form 4 filings. Their most recent trade was for 10,290 units of RYTM stock on 03/18/2019. Their biggest sale was on 11/02/2018 when they sold 16,500 units of Rhythm Pharmaceuticals Inc stock for $496,320.00. They typically trade 5 times per year.
Total value of insider buys:
- $74,944.00
Total value of insider sells:
- $2,462,159.84
Most recent insider trade:
- March 18, 2019
Keith Michael Gottesdiener's Insider Trading History
| Rhythm Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 18, 2019 | CEO | 10,290 | $30.09 | Sell | $309,626.10 |
March 14, 2019 | CEO | 9,288 | $30.06 | Sell | $279,197.28 |
Feb. 27, 2019 | CEO | 2,449 | $30.04 | Sell | $73,567.96 |
Feb. 19, 2019 | CEO | 12,920 | $30.02 | Sell | $387,858.40 |
Feb. 13, 2019 | CEO | 3,934 | $30.00 | Sell | $118,020.00 |
Jan. 23, 2019 | CEO | 15,779 | $30.05 | Sell | $474,158.95 |
Jan. 18, 2019 | CEO | 10,115 | $30.01 | Sell | $303,551.15 |
Jan. 16, 2019 | CEO | 662 | $30.00 | Sell | $19,860.00 |
Nov. 2, 2018 | CEO | 16,500 | $30.08 | Sell | $496,320.00 |
| Intercept Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 9, 2018 | Director | 1,171 | $64.00 | Buy | $74,944.00 |